Skip to main content
SpringerLink
Log in

Patient History

  • Chapter
  • First Online:
Voice Disorders in Athletes, Coaches and other Sports Professionals

Abstract

The medical history in voice patients must be comprehensive. Virtually, all body systems can contribute to voice function and dysfunction. An appropriate history includes not just all aspects of voice use (professional and nonprofessional), smoking, occupation, allergies, and other obvious factors. Other systems also may cause or contribute to voice disorders including gastroenterological (especially reflux), endocrinologic (hormones), respiratory (asthma, chronic obstructive pulmonary disease, and others), musculoskeletal, and other systems. An understanding of the function of the entire body is needed in order to diagnose and treat voice disorders correctly.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sataloff RT. Professional singers: the science and art of clinical care. Am J Otolaryngol. 1981;2:251–66.

    Article  CAS  PubMed  Google Scholar 

  2. Sataloff RT. The human voice. Sci Am. 1992;267:108–15.

    Article  CAS  PubMed  Google Scholar 

  3. Sundberg J. The science of the singing voice. DeKalb: Northern Illinois University Press; 1987.

    Google Scholar 

  4. Sataloff RT. Efficient history taking in professional singers. Laryngoscope. 1984;94:1111–4.

    CAS  PubMed  Google Scholar 

  5. Ackerman R, Pfan W. Gerontology studies on the susceptibility to voice disorders in professional speakers. Folia Phoniatr (Basel). 1974;26:95–9.

    Article  Google Scholar 

  6. von Leden H. Speech and hearing problems in the geriatric patient. J Am Geriatr Soc. 1977;25:422–6.

    Article  Google Scholar 

  7. Schiff M. Comment. Presented at: seventh symposium on care of the professional voice; June 15–16, 1978. New York: The Juilliard School.

    Google Scholar 

  8. Spiegel JR, Cohn JR, Sataloff RT, et al. Respiratory function in singers: medical assessment, diagnoses, treatments. J Voice. 1988;2:40–50.

    Article  Google Scholar 

  9. Cohn JR, Sataloff RT, Spiegel JR, et al. Airway reactivity-induced asthma in singers (ARIAS). J Voice. 1991;5:332–7.

    Article  Google Scholar 

  10. Feder RJ. The professional voice and airline flight. Otolaryngol Head Neck Surg. 1984;92:251–4.

    Article  CAS  PubMed  Google Scholar 

  11. Anticaglia A, Hawkshaw M, Sataloff RT. The effects of smoking on voice performance. J Singing. 2004;60:161–7.

    Google Scholar 

  12. Centers for Disease Control and Prevention (CDC). Annual smoking-attributable, mortality, years of potential life lost, and economic costs, United States—1995–1999. MMWR Morb Mortal Wkly Rep. 2002;51(14):300–3.

    Google Scholar 

  13. World Health Organization. World health report 1999. Geneva: World Health Organization; 1999.

    Google Scholar 

  14. United States Department of Health Services (USDHHS). Tobacco products fact sheet. Washington: Government Printing Office; 2000.

    Google Scholar 

  15. National Cancer Institute. Environmental tobacco smoke. Fact sheet 3.9; 1999. http://cis.nci.nih.gov/fact/3_9.htm.

  16. Centers for Disease Control and Prevention. Cigarette smoking among adults—United States, 1993. MMWR Morb Mortal Wkly Rep. 1994;3:925–9.

    Google Scholar 

  17. Chow WH, McLaughlin JK, Hrubec Z, et al. Tobacco use and nasopharyngeal carcinoma in a cohort of US veterans. Int J Cancer. 1993;55(4):538–40.

    Article  CAS  PubMed  Google Scholar 

  18. Casiglia J, Woo SB. A comprehensive view of oral cancer. Gen Dent. 2001;49(1):72–82.

    CAS  PubMed  Google Scholar 

  19. Centers for Disease Control and Prevention. Determination of nicotine pH and moisture content of six U.S. commercial moist snuff products. MMWR Morb Mortal Wkly Rep. 1999;48(19):398.

    Google Scholar 

  20. American Cancer Society. Cancer facts and figures 2002. Atlanta: American Cancer Society; 2002.

    Google Scholar 

  21. National Toxicology Program (NTP). Report on carcinogens. 10th ed. Research Triangle Park, NC: U.S. Department Health and Human Services, Public Health Service, National Toxicology Program; 2002. http://ehp.niehs.nih.gov/roc/toc10.html.

    Google Scholar 

  22. Academy of Pediatrics, Committee on Environmental Health. Environmental tobacco smoke; a hazard to children. Pediatrics. 1997;99(4):639–42.

    Article  Google Scholar 

  23. Rosen DC, Sataloff RT. Psychology of voice disorders. 2nd ed. San Diego: Plural Publishing, Inc.; 2020.

    Google Scholar 

  24. Gupta OP, Bhatia PL, Agarwal MK, et al. Nasal pharyngeal and laryngeal manifestations of hypothyroidism. Ear Nose Throat J. 1997;56:10–21.

    Google Scholar 

  25. Malinsky M, Chevrie-Muller C, Cerceau N. Etude clinique et electrophysiologique des alterations de la voix au cours des thyrotoxioses. Ann Endocrinol (Paris). 1997;38:171–2.

    Google Scholar 

  26. Michelsson K, Sirvio P. Cry analysis in congenital hypothyroidism. Folia Phoniatr (Basel). 1976;28:40–7.

    Article  CAS  Google Scholar 

  27. Ritter FN. The effect of hypothyroidism on the larynx of the rat. Ann Otol Rhinol Laryngol. 1964;67:404–16.

    Article  Google Scholar 

  28. Ritter FN. Endocrinology. In: Paparella M, Shumrick D, editors. Otolaryngology, vol. I. Philadelphia: Saunders; 1973. p. 727–34.

    Google Scholar 

  29. Meuser W, Nieschlag E. Sex hormones and depth of voice in the male [in German]. Dtsch Med Wochenschr. 1977;102:261–4.

    Article  CAS  PubMed  Google Scholar 

  30. Schiff M. The influence of estrogens on connective tissue. In: Asboe-Hansen G, editor. Hormones and connective tissue. Copenhagen: Munksgaard Press; 1967. p. 282–341.

    Google Scholar 

  31. Brodnitz F. The age of the castrato voice. J Speech Hear Disord. 1975;40:291–5.

    Article  CAS  PubMed  Google Scholar 

  32. Brodnitz F. Hormones and the human voice. Bull N Y Acad Med. 1971;47:183–91.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. von Gelder L. Psychosomatic aspects of endocrine disorders of the voice. J Commun Disord. 1974;7:257–62.

    Article  PubMed  Google Scholar 

  34. Lacina O. Der Einfluss der Menstruation auf die Stimme der Sangerinnen. Folia Phoniatr (Basel). 1968;20:13–24.

    Article  CAS  Google Scholar 

  35. Wendler J. The influence of menstruation on the voice of the female singer. Folia Phoniatr (Basel). 1972;24:259–77.

    Article  CAS  Google Scholar 

  36. Brodnitz F. Medical care preventive therapy (Panel). In: Lawrence VL, editor. Transcripts of the seventh annual symposium, care of the professional voice, vol. 3. New York: The Voice Foundation; 1978. p. 86.

    Google Scholar 

  37. Dordain M. Etude Statistique de l’influence des contraceptifs hormonaux sur la voix. Folia Phoniatr (Basel). 1972;24:86–96.

    Article  CAS  Google Scholar 

  38. Pahn J, Goretzlehner G. Voice changes following the use of oral contraceptives [in German]. Zentralbl Gynakol. 1978;100:341–6.

    CAS  PubMed  Google Scholar 

  39. Schiff M. “The pill” in otolaryngology. Trans Am Acad Ophthalmol Otolaryngol. 1968;72:76–84.

    CAS  PubMed  Google Scholar 

  40. von Deuster CV. Irreversible vocal changes in pregnancy [in German]. HNO. 1977;25:430–2.

    Google Scholar 

  41. Flach M, Schwickardi H, Simen R. Welchen Einfluss haben Menstruation and Schwangerschaft auf die augsgebildete Gesangsstimme? Folia Phoniatr (Basel). 1968;21:199–210.

    Article  Google Scholar 

  42. Arndt HJ. Stimmstorungen nach Behandlung mit Androgenen und anabolen Hormonen. Munch Med Wochenschr. 1974;116:1715–20.

    CAS  Google Scholar 

  43. Bourdial J. Les troubles de la voix provoques par la therapeutique hormonale androgene. Ann Otolaryngol Chir Cervicofac. 1970;87:725–34.

    CAS  PubMed  Google Scholar 

  44. Damste PH. Virilization of the voice due to anabolic steroids [in Dutch]. Ned Tijdschr Geneeskd. 1963;107:891–2.

    CAS  PubMed  Google Scholar 

  45. Damste PH. Voice changes in adult women caused by virilizing agents. J Speech Hear Disord. 1967;32:126–32.

    Article  CAS  PubMed  Google Scholar 

  46. Saez S, Francoise S. Recepteurs d’androgenes: mise en evidence dans la fraction cytosolique de muqueuse normale et d’epitheliomas phryngolarynges humains. C R Acad Hebd Seances Acad Sci D. 1975;280:935–8.

    CAS  PubMed  Google Scholar 

  47. Vuorenkoski V, Lenko HL, Tjernlund P, et al. Fundamental voice frequency during normal and abnormal growth, and after androgen treatment. Arch Dis Child. 1978;53:201–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Imre V. Hormonell bedingte Stimmstorungen. Folia Phoniatr (Basel). 1968;20:394–404.

    Article  CAS  Google Scholar 

  49. Sundberg J, Prame E, Iwarsson J. Replicability and accuracy of pitch patterns in professional singers. In: Davis PJ, Fletcher NH, editors. Vocal fold physiology: controlling chaos and complexity. San Diego: Singular Publishing Group; 1996. p. 291–306.

    Google Scholar 

  50. Gould WJ, Alberti PW, Brodnitz F, Hirano M. Medical care preventive therapy [Panel]. In: Lawrence VL, editor. Transcripts of the seventh annual symposium; care of the professional voice, vol. 3. New York: The Voice Foundation; 1978. p. 74–6.

    Google Scholar 

  51. Wallner LJ, Hill BJ, Waldrop W, Monroe C. Voice changes following adenotonsillectomy. Laryngoscope. 1968;78:1410–8.

    Article  CAS  PubMed  Google Scholar 

  52. Lawrence VL. Medical care for professional voice (Panel). In: Lawrence VL, editor. Transcripts from the annual symposium, care of the professional voice, vol. 3. New York: The Voice Foundation; 1978. p. 17–8.

    Google Scholar 

  53. Cannon CP. COX-2 inhibitors and cardiovascular risk. Science. 2012;336(6087):1386–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Modified in part from Sataloff RT. Professional Voice: The Science and Art of Clinical Care, 4th Edition. San Diego, CA: Plural Publishing; 2017, with permission.

Author information

Authors and Affiliations

  1. Department of Otolaryngology – Head and Neck Surgery, Drexel University College of Medicine, Philadelphia, PA, USA

    Robert Thayer Sataloff

  2. Lankenau Institute for Medical Research, Wynnewood, PA, USA

    Robert Thayer Sataloff

Authors
  1. Robert Thayer Sataloff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert Thayer Sataloff .

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sataloff, R.T. (2021). Patient History. In: Voice Disorders in Athletes, Coaches and other Sports Professionals. Springer, Cham. https://doi.org/10.1007/978-3-030-69831-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-69831-7_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-69830-0

  • Online ISBN: 978-3-030-69831-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation